Brief: Alligator Announces Final 30-Month Optimize-1 Results
Sept 22 (Reuters) - Alligator Bioscience AB ATORX.ST: ALLIGATOR ANNOUNCES FINAL 30-MONTH OPTIMIZE-1 RESULTS HIGHLIGHTING THE POTENTIAL OF MITAZALIMAB IN METASTATIC PANCREATIC CANCER Source text: ID:nMFN5FFLqB Further company coverage: ATORX.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue